延江股份(300658.SZ):1.08億股限售股6月2日解禁
格隆匯5月27日丨延江股份(300658.SZ)公佈,此次解除股份限售的股東共8名,分別為謝繼華、謝繼權、謝影秋、謝淑冬、謝道平、林彬彬、廈門市延興投資管理合夥企業(有限合夥)、廈門市興延投資管理合夥企業(有限合夥)。此次可解除限售股份數量為1.08億股,佔公司股本總額比例為71.2049%;實際可上市流通股份數量為1080萬股,佔公司總股本的7.1205%。此次限售股份可上市流通日為2020年6月2日(星期二)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.